International Stem
Cell Corp., the developer of a new stem cell technology called parthenogenesis,
is focused on the application of its research and development to the treatment
of human degenerative diseases.
The company’s human
parthenogenetic stem cells (hpSCs), derived from unfertilized human eggs, have
the best characteristics of each of the most commonly used and described
classes of stem cells – induced pluripotent stem cells, embryonic stem cells,
and adult stem cells – thereby creating a class of cells that meet all
important criteria when it comes to therapeutic application.
hsPCs’ are immune
matching, which means that millions of patients could receive tissue and cell
transplants without tissue rejection problems or the need to take immune-suppressing
drugs; pluripotent, meaning they can change or “differentiate” into more
specialized cells such as skin, liver or blood cells; demonstrate strong
proliferation in culture, which refers to the growth of the cell populations in
the research and/or application environment; and are considered superior in
their use in genetic disease.
Leveraging these
capabilities and characteristics, International Stem Cell aims to use its hsPCs
to treat diseases of the brain (Parkinson’s diseases), liver (treatment of liver
damage) and eye (cornea tissue implants). In support of these goals, the
company is also building its stem cell bank (UniStemCell) of parthenogenetic
stem cell lines for research and commercial use.
International Stem
Cell’s subsidiary business units, Lifeline Cell Technology (LCT) and Lifeline
Skin Care (LSC), further support the company and create a business model unique
to the biotechnology industry, creating revenue flow from the sale of products
develop from scientific discoveries made by International Stem Cell. This
self-sustaining model not only allows for the allocation of revenues to further
support scientific research and development, but also provides practical,
short-term applications of the company’s core technologies.
For more information
visit www.internationalstemcell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment